IGF1R
IGF1R is the transmembrane tyrosine kinase receptor for IGF-1 that activates PI3K/AKT/mTOR and RAS/MAPK signaling cascades. Partial loss-of-function is enriched in human centenarians and extends lifespan in multiple model organisms.
Key Takeaways
- •IGF1R is the primary receptor mediating the growth and survival signals of IGF-1 and IGF-2.
- •Reduced IGF1R signaling is one of the most robust and conserved pathways for extending lifespan across species.
- •Centenarian studies show that humans with lower IGF1R activity often live significantly longer.
- •Mutations in IGF1R can cause growth deficiency, while overactivity is strongly linked to cancer progression.
Basic Information
- Gene Symbol
- IGF1R
- Full Name
- Insulin-like Growth Factor 1 Receptor
- Also Known As
- CD221IGFIR
- Location
- 15q26.3
- Protein Type
- Receptor Tyrosine Kinase
- Protein Family
- Insulin receptor family
Related Isoforms
Shares structural homology; can form Hybrid Receptors with IGF1R.
A "decoy" receptor that sequesters IGF-2, often antagonizing IGF1R.
Key SNPs
G/A (Glu1013Lys). One of the most studied variants; the A allele is enriched in centenarians and associated with reduced IGF1R signaling and smaller body size.
Associated with longevity in several cohorts; may influence receptor expression or stability.
GWAS-identified locus for human height; likely regulates IGF1R expression levels.
Located in a regulatory region; studied in relation to breast cancer risk and receptor density.
Associated with metabolic traits including fasting insulin and glucose handling.
May influence transcriptional activity of the IGF1R gene.
Overview
The Insulin-like Growth Factor 1 Receptor (IGF1R) is a critical cell surface protein that translates extracellular growth cues into intracellular action. It is essential for normal growth during development and continues to play a major role in adult metabolism, cell survival, and protein synthesis. However, it is also the most famous "longevity gene" in biology; reducing its activity is the most reliable way to extend lifespan in model organisms.
IGF1R is a tetrameric receptor consisting of two α and two β subunits. When IGF-1 binds, it triggers a conformational change that allows the β subunits to phosphorylate each other, creating docking sites for downstream signaling molecules like IRS-1.
Conceptual Model
A simplified mental model for the pathway:
High IGF1R activity = High Growth / Low Maintenance. Low IGF1R activity = Low Growth / High Maintenance (Longevity).
Core Health Impacts
- • Growth & Maintenance: Essential for skeletal growth and muscle mass maintenance
- • Anti-apoptosis: Potent anti-apoptotic signal (prevents cell death)
- • Longevity Node: Primary driver of the PI3K/AKT/mTOR longevity axis
- • Metabolic Regulation: Regulates glucose metabolism and insulin sensitivity
- • Neuroprotection: Mediates neuroprotective effects in the brain
Protein Domains
Extracellular α-subunits
Contain the ligand-binding domain (LBD). These subunits extend outside the cell to capture IGF-1 and IGF-2 molecules.
Transmembrane β-subunits
Anchor the receptor in the membrane and contain the intracellular kinase domain responsible for signal transduction.
Tyrosine Kinase Domain
The "engine room" that phosphorylates tyrosine residues on target proteins (IRS1/2) to initiate the signaling cascade.
Upstream Regulators
IGF-1 Activator
The primary high-affinity ligand; induces receptor dimer autophosphorylation and recruitment of IRS1/2.
IGF-2 Activator
Binds IGF1R with lower affinity than IGF-1 but is a potent activator during fetal development and in certain cancers.
Insulin Activator
Can bind IGF1R at high physiological concentrations, particularly when insulin levels are pathologically elevated.
Growth Hormone (GH) Activator
Indirectly activates IGF1R by stimulating hepatic and local IGF-1 production.
Integrin αVβ3 Activator
Interacts with IGF1R at the cell membrane to enhance signaling efficiency and cell migration.
GPCRs (e.g., Thrombin) Activator
Can "transactivate" IGF1R through intracellular cross-talk, even in the absence of IGF ligands.
Downstream Targets
IRS1 / IRS2 Activates
Primary adapter proteins that dock to the phosphorylated receptor to initiate the PI3K and MAPK cascades.
PI3K / AKT Activates
The major survival and growth pathway; promotes protein synthesis and inhibits apoptosis.
MAPK / ERK Activates
Drives cell proliferation, differentiation, and gene expression changes in response to growth factors.
SHC Activates
Adapter protein involved in coupling IGF1R activation to the Ras/MAPK pathway.
mTORC1 Activates
Downstream of AKT; coordinates protein synthesis and nutrient sensing.
FOXO transcription factors Inhibits
Inhibited by IGF1R signaling (via AKT), reducing stress resistance and longevity-promoting gene expression.
Role in Aging
IGF1R is arguably the most important node in the biology of aging. Across species, lower IGF1R activity is linked to longer life. This is because IGF1R signaling prioritizes immediate growth and reproduction over the cellular "housekeeping" tasks (like DNA repair and autophagy) that prevent aging.
Conserved Longevity Pathway
In C. elegans, mutations in daf-2 (the IGF1R/INSR homolog) can double or triple lifespan. This same principle holds in fruit flies and mice, where IGF1R reduction extends life.
The Centenarian Link
Human studies of centenarians and their offspring show an enrichment of IGF1R mutations that slightly impair receptor function, suggesting that humans follow the same biological rules as model organisms.
Trade-off with Body Size
Low IGF1R signaling often results in smaller body size (as seen in small dog breeds and Laron syndrome humans). This "smallness" is statistically correlated with longevity within many species.
Stress Resistance
Lowering IGF1R activity increases a cell’s ability to withstand heat, oxidative stress, and toxic proteins by allowing FOXO transcription factors to remain active in the nucleus.
Autophagy Gating
IGF1R → AKT → mTOR signaling is the primary "off-switch" for autophagy. Reducing this signaling allows for more frequent cellular cleanup and removal of damaged organelles.
Proteostasis Maintenance
By slowing down global protein synthesis and increasing degradation of misfolded proteins, reduced IGF1R signaling helps maintain a clean and functional proteome into old age.
Disorders & Diseases
Cancer Progression
IGF1R is overexpressed in many cancers (breast, prostate, lung). It provides a powerful survival signal that helps tumors resist chemotherapy and radiation.
Growth Deficiency
Loss-of-function mutations in IGF1R lead to IGF-1 resistance. Patients typically show intrauterine growth restriction (IUGR), short stature, and microcephaly, often with high serum IGF-1 levels because the body tries to compensate.
Metabolic Syndrome & T2D
While often overshadowed by the Insulin Receptor, IGF1R is involved in glucose handling. Specific variants (like G310D) are associated with increased risk of Type 2 Diabetes and poor metabolic health.
Neurodegenerative Disease
IGF1R signaling in the brain is neuroprotective, but its role in aging is paradoxical: while high signaling supports neuron survival, low signaling may reduce the accumulation of toxic proteins (amyloid/τ) by boosting autophagy.
Interventions
Supplements
Polyphenol that may modulate the IGF-1 axis and support SIRT1-mediated stress responses.
Reported to inhibit IGF1R phosphorylation and downstream signaling in various cell models.
Flavonoid that can interfere with receptor tyrosine kinase activity, including IGF1R.
Studies suggest it may lower IGF-1 levels and modulate receptor activity.
Influences Nrf2 and may indirectly balance growth signaling through stress-response pathways.
Lifestyle
One of the most effective ways to lower circulating IGF-1, reducing the activation pressure on IGF1R.
Consistently reduces IGF-1/IGF1R signaling intensity, a key mechanism for its longevity-extending effects.
Triggers a significant drop in IGF-1 and changes in IGFBPs that reduce receptor activation.
Necessary for rhythmic GH/IGF-1 pulsatility; chronic sleep deprivation can dysregulate the axis.
Medicines
Experimental drugs (e.g., Ganitumab, Figitumumab) designed to block the receptor in cancer treatment.
Small molecules that block the catalytic activity of the receptor. Examples include linsitinib.
Improves insulin sensitivity and may modestly lower IGF-1 levels, indirectly affecting receptor activation.
Used to treat acromegaly by inhibiting GH secretion, thereby lowering IGF-1/IGF1R signaling.
Lab Tests & Biomarkers
Indirect Activity
The best proxy for receptor activation. High levels indicate high upstream pressure on IGF1R.
High levels usually correlate with total IGF-1; the ratio is often used to estimate "free" IGF-1.
Helps distinguish between growth-driven and metabolic-driven signaling states.
Genetic Testing
Screening for rs2229765 and other longevity-associated variants.
Used in pediatric endocrinology to diagnose genetic short stature (IGF-1 resistance).
Downstream Readouts
Indicates the receptor is successfully transmitting signals into the cell.
Nuclear FOXO (good) suggests low IGF1R activity; Cytoplasmic FOXO (bad) suggests high activity.
Hormonal Interactions
IGF-1 Primary Ligand
High-affinity activator driving most of the receptor’s growth and survival effects.
IGF-2 Secondary Ligand
Important in development; can drive tumor growth via IGF1R in adults.
Insulin Weak Activator
Can activate IGF1R directly or via Hybrid Receptors (IR/IGF1R) during hyperinsulinemia.
Growth Hormone Master Regulator
Controls the supply of the IGF-1 ligand; excessive GH leads to chronic IGF1R overactivation.
IGFBP-3 Modulator
The primary binding protein that sequesters IGF-1, controlling its availability to the receptor.
Cortisol Antagonist
Glucocorticoids can inhibit IGF1R expression and signaling, contributing to muscle wasting.
Deep Dive
Network Diagrams
IGF1R Activation & Recruitment
IGF1R Pathway Integration
Structural Logic: The “Auto-Inhibition” Switch
IGF1R exists as a pre-formed dimer, but it stays “off” due to a specific structural arrangement of its intracellular β-subunits. This is called auto-inhibition.
Ligand Binding: When IGF-1 binds to the extracellular α-subunits, it forces a rotation and tilt of the transmembrane domains. This repositioning brings the internal kinase domains close enough to “reach” each other.
Trans-phosphorylation: Once in proximity, one β-subunit phosphorylates the other. This unlocks the kinase domain, allowing it to phosphorylate downstream adapters like IRS1 and SHC.
Hybrid Receptors: Because IGF1R is so similar to the Insulin Receptor (INSR), cells often produce “Hybrid Receptors” consisting of one half IGF1R and one half INSR. These hybrids complicate the signaling landscape, as they can respond to both insulin and IGF-1 but with different efficiencies.
The IGF1R Longevity Paradox: Growth vs. Repair
Why would reducing a “growth” receptor make an animal live longer? The answer lies in resource allocation.
High IGF1R Tone: The cell receives a signal that nutrients are plentiful and growth is the priority. It activates mTOR (to build protein) and shuts down FOXO (to stop repair). This is great for youth and reproduction but leads to the accumulation of cellular “garbage” over time.
Low IGF1R Tone: The cell perceives a “scarcity” or “maintenance” mode. It keeps mTOR low (saving energy) and allows FOXO to enter the nucleus. FOXO then turns on hundreds of genes for stress resistance, DNA repair, and antioxidant defense.
Human Centenarians: In humans, the most famous longevity variant (rs2229765) results in a slightly less efficient receptor. It doesn’t break the system, but it shifts the dial just enough toward repair to provide a lifelong advantage in slowing down molecular aging.
Feedback & Integration: The IR/IGF1R Network
IGF1R doesn’t act in a vacuum; it is part of a complex network that integrates nutrient sensing with growth signaling.
S6K Feedback: Just like with the Insulin Receptor, overactivation of mTOR/S6K can feed back and phosphorylate IRS1 on “inhibitory” serine sites. This creates a state of IGF-1 resistance, where the receptor is present but the signal can’t get through.
IGFBP Modulation: IGF-Binding Proteins (IGFBPs) act as a sophisticated “buffer” system. They can either protect IGF-1 from degradation or prevent it from reaching the receptor, effectively tuning the gain of the IGF1R signal.
Cross-talk with Integrins: IGF1R signaling is significantly enhanced when cells are attached to the extracellular matrix via integrins. This ensures that cells only grow and divide when they are in the correct physical location.
Practical Notes for Genetic Analysis
Context is King: An "A" allele at rs2229765 might be a longevity marker, but its effects are modulated by your protein intake and lifestyle. High protein intake can "overpower" the benefit of a low-activity receptor.
IGF-1 Resistance: If you see high serum IGF-1 but have symptoms of low IGF-1 (like low muscle mass or poor recovery), it may indicate receptor-level resistance or genetic variants in IGF1R.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
First major study showing that IGF1R haploinsufficiency (half dosage) extends lifespan in mice while maintaining health.
Identified IGF1R variants in human centenarians that reduce receptor signaling, mirroring findings in model organisms.
Structural biology study clarifying the mechanism of autophosphorylation and the transition to an active state.
Comprehensive review of clinical disorders linked to IGF1R mutations, including short stature and metabolic dysfunction.
Explored the nuances of IGF1R reduction on aging phenotypes, noting significant sex-specific effects in mice.
Established the link between human IGF1R loss-of-function mutations and intrauterine growth restriction and short stature.